OR WAIT null SECS
Contract service providers must step up their game to stay competitive in increasingly complex bio/pharma market.
The need for preclinical testing expertise is growing as molecular complexity increases.
A look at the newest innovations offers a deeper understanding of affinity ligands and their role in the future of downstream processing.
April 01, 2007
Liability issues are often controversial, but much depends on the nature of the agreement.
March 30, 2007
As big pharmaceutical companies restructure and reevaluate the way they do business, contract research and manufacturing organizations could reap greater financial rewards.
March 02, 2007
The low-volume pharmaceutical industry must adapt Lean Manufacturing tools invented for high-volume, single product industries.
March 01, 2007
While the Gulf region has already become well-known for its globally accepted infrastructure, and large projects in tourism and other service areas, major investments in healthcare or pharmaceuticals have failed to develop as well.
Finding a CMO partner will take time and an incorrect choice that leads to changing the CMO is financially very painful.
Although the CRO may not wish to draw attention to weaknesses in the intended trial, failing to do so is a great disservice.
February 28, 2007
Sixty deals were completed in 2006, with a total value of $2 billion.
The latest pacts from the pharmaceutical supply chain.
The latest regulatory and association news for pharmaceutical manufacturers and contract manufacturing organizations.